{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:30:23Z","timestamp":1794069023979,"version":"4.8.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","funder":[{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["217G18a"],"award-info":[{"award-number":["217G18a"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["190F15a"],"award-info":[{"award-number":["190F15a"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001296","name":"PKD Foundation","doi-asserted-by":"publisher","award":["207F17a"],"award-info":[{"award-number":["207F17a"]}],"id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK100592"],"award-info":[{"award-number":["DK100592"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK51041"],"award-info":[{"award-number":["DK51041"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK090728"],"award-info":[{"award-number":["DK090728"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["GM111913"],"award-info":[{"award-number":["GM111913"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK106515-01"],"award-info":[{"award-number":["DK106515-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 DK079310"],"award-info":[{"award-number":["P30 DK079310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["M#UM1HG006504-05"],"award-info":[{"award-number":["M#UM1HG006504-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2019,11]]},"abstract":"\n Significance Statement<\/jats:title>\n \n Dominantly inherited polycystic kidney and liver phenotypes occur when epithelial cells in these organs have reduction of polycystin-1 functional dosage. In a cohort of genetically unresolved polycystic liver and kidney disease, the authors identified heterozygous loss of function mutations in\n ALG9<\/jats:italic>\n .\n ALG9<\/jats:italic>\n encodes an endoplasmic reticulum enzyme that builds\n N<\/jats:italic>\n -glycans, and the authors show that\n Alg9<\/jats:italic>\n inactivation results in impaired polycystin-1 maturation. Using a novel \u2018genotype-first\u2019 approach to ascertain individuals based strictly on their\n ALG9<\/jats:italic>\n genotype from a large cohort of exome-sequenced individuals, the authors find that 7\/8 (88%) of\n ALG9<\/jats:italic>\n mutation carriers over age 50 have multiple kidney cysts. Together, these findings identify\n ALG9<\/jats:italic>\n as a novel human polycystic kidney and liver disease gene and support the utility of a genotype-driven approach to candidate disease gene validation and genotype-phenotype correlation.\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n \n Mutations in\n PKD1<\/jats:italic>\n or\n PKD2<\/jats:italic>\n cause typical autosomal dominant polycystic kidney disease (ADPKD), the most common monogenic kidney disease. Dominantly inherited polycystic kidney and liver diseases on the ADPKD spectrum are also caused by mutations in at least six other genes required for protein biogenesis in the endoplasmic reticulum, the loss of which results in defective production of the\n PKD1<\/jats:italic>\n gene product, the membrane protein polycystin-1 (PC1).\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n We used whole-exome sequencing in a cohort of 122 patients with genetically unresolved clinical diagnosis of ADPKD or polycystic liver disease to identify a candidate gene,\n ALG9<\/jats:italic>\n , and\n in vitro<\/jats:italic>\n cell-based assays of PC1 protein maturation to functionally validate it. For further validation, we identified carriers of\n ALG9<\/jats:italic>\n loss-of-function mutations and noncarrier matched controls in a large exome-sequenced population-based cohort and evaluated the occurrence of polycystic phenotypes in both groups.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Two patients in the clinically defined cohort had rare loss-of-function variants in\n ALG9<\/jats:italic>\n , which encodes a protein required for addition of specific mannose molecules to the assembling N-glycan precursors in the endoplasmic reticulum lumen.\n In vitro<\/jats:italic>\n assays showed that inactivation of\n Alg9<\/jats:italic>\n results in impaired maturation and defective glycosylation of PC1. Seven of the eight (88%) cases selected from the population-based cohort based on\n ALG9<\/jats:italic>\n mutation carrier state who had abdominal imaging after age 50; seven (88%) had at least four kidney cysts, compared with none in matched controls without\n ALG9<\/jats:italic>\n mutations.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n ALG9<\/jats:italic>\n is a novel disease gene in the genetically heterogeneous ADPKD spectrum. This study supports the utility of phenotype characterization in genetically-defined cohorts to validate novel disease genes, and provide much-needed genotype-phenotype correlations.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1681\/asn.2019030298","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T15:15:14Z","timestamp":1565277314000},"page":"2091-2102","source":"Crossref","is-referenced-by-count":159,"title":["ALG9 Mutation Carriers Develop Kidney and Liver Cysts"],"prefix":"10.1681","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-1507","authenticated-orcid":false,"given":"Whitney","family":"Besse","sequence":"first","affiliation":[{"name":"Internal Medicine (Nephrology) and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Chang","sequence":"additional","affiliation":[{"name":"Nephrology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2567-1516","authenticated-orcid":false,"given":"Jonathan Z.","family":"Luo","sequence":"additional","affiliation":[{"name":"Molecular and Functional Genomics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Triffo","sequence":"additional","affiliation":[{"name":"Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryn S.","family":"Moore","sequence":"additional","affiliation":[{"name":"Molecular and Functional Genomics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashima","family":"Gulati","sequence":"additional","affiliation":[{"name":"Internal Medicine (Nephrology) and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9057-2832","authenticated-orcid":false,"given":"Dustin N.","family":"Hartzel","sequence":"additional","affiliation":[{"name":"Biomedical and Translational Informatics, Geisinger Clinic, Danville, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrikant","family":"Mane","sequence":"additional","affiliation":[{"name":"Genetics, Yale University School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Regeneron Genetics Center","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Somlo","sequence":"additional","affiliation":[{"name":"Internal Medicine (Nephrology) and"},{"name":"Genetics, Yale University School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooraj","family":"Mirshahi","sequence":"additional","affiliation":[{"name":"Biomedical and Translational Informatics, Geisinger Clinic, Danville, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,8,8]]},"reference":[{"key":"B1-20230819","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease.","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"B2-20230819","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases.","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B3-20230819","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1086\/368295","article-title":"Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.","volume":"72","author":"Li","year":"2003","journal-title":"Am J Hum Genet"},{"key":"B4-20230819","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1104","article-title":"Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.","volume":"33","author":"Drenth","year":"2003","journal-title":"Nat Genet"},{"key":"B5-20230819","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng1357","article-title":"Mutations in SEC63 cause autosomal dominant polycystic liver disease.","volume":"36","author":"Davila","year":"2004","journal-title":"Nat Genet"},{"key":"B6-20230819","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease.","volume":"98","author":"Porath","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B7-20230819","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1172\/JCI96729","article-title":"Isolated polycystic liver disease genes define effectors of polycystin-1 function.","volume":"127","author":"Besse","year":"2017","journal-title":"J Clin Invest"},{"key":"B8-20230819","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease.","volume":"102","author":"Cornec-Le Gall","year":"2018","journal-title":"Am J Hum Genet"},{"key":"B9-20230819","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2003.50006","article-title":"Clinical profile of autosomal dominant polycystic liver disease.","volume":"37","author":"Qian","year":"2003","journal-title":"Hepatology"},{"key":"B10-20230819","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0092-8674(00)81793-6","article-title":"The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.","volume":"87","author":"Qian","year":"1996","journal-title":"Cell"},{"key":"B11-20230819","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","article-title":"Somatic inactivation of Pkd2 results in polycystic kidney disease.","volume":"93","author":"Wu","year":"1998","journal-title":"Cell"},{"key":"B12-20230819","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1097-2765(00)80135-5","article-title":"Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease.","volume":"2","author":"Watnick","year":"1998","journal-title":"Mol Cell"},{"key":"B13-20230819","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/gutjnl-2014-308062","article-title":"Somatic loss of polycystic disease genes contributes to the formation of isolated and polycystic liver cysts.","volume":"64","author":"Janssen","year":"2015","journal-title":"Gut"},{"key":"B14-20230819","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1681\/ASN.2017080878","article-title":"Somatic mutations in renal cyst epithelium in autosomal dominant polycystic kidney disease.","volume":"29","author":"Tan","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"B15-20230819","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ng.860","article-title":"A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation.","volume":"43","author":"Fedeles","year":"2011","journal-title":"Nat Genet"},{"key":"B16-20230819","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ymgmr.2017.08.004","article-title":"ALG9-CDG: New clinical case and review of the literature.","volume":"13","author":"Davis","year":"2017","journal-title":"Mol Genet Metab Rep"},{"key":"B17-20230819","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrg1894","article-title":"Genetic defects in the human glycome.","volume":"7","author":"Freeze","year":"2006","journal-title":"Nat Rev Genet"},{"key":"B18-20230819","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ejhg.2015.91","article-title":"A novel phenotype in N-glycosylation disorders: Gillessen-Kaesbach-Nishimura skeletal dysplasia due to pathogenic variants in ALG9.","volume":"24","author":"Tham","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"B19-20230819","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40556-018-0183-1","article-title":"ALG9 associated gillessen-kaesbach\u2013nishimura syndrome (GIKANIS): An uncommon aetiology of enlarged foetal kidneys.","volume":"5","author":"Arora","year":"2018","journal-title":"J Foetal Med"},{"key":"B20-20230819","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"B21-20230819","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease.","volume":"371","author":"Torres","year":"2014","journal-title":"N Engl J Med"},{"key":"B22-20230819","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants.","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet"},{"key":"B23-20230819","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans.","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"B24-20230819","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nbt.2835","article-title":"Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls.","volume":"32","author":"Zook","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B25-20230819","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","article-title":"Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies.","volume":"24","author":"Dong","year":"2015","journal-title":"Hum Mol Genet"},{"key":"B26-20230819","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: An ensemble method for predicting the pathogenicity of rare missense variants.","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B27-20230819","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/bioinformatics\/btv009","article-title":"An integrative approach to predicting the functional effects of non-coding and coding sequence variation.","volume":"31","author":"Shihab","year":"2015","journal-title":"Bioinformatics"},{"key":"B29-20230819","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/gim.2015.187","article-title":"The Geisinger MyCode community health initiative: An electronic health record-linked biobank for precision medicine research.","volume":"18","author":"Carey","year":"2016","journal-title":"Genet med"},{"key":"B30-20230819","doi-asserted-by":"crossref","first-page":"aaf6814","DOI":"10.1126\/science.aaf6814","article-title":"Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study.","volume":"354","author":"Dewey","year":"2016","journal-title":"Science"},{"key":"B31-20230819","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ajhg.2018.03.012","article-title":"Profiling and leveraging relatedness in a precision medicine cohort of 92,455 exomes.","volume":"102","author":"Staples","year":"2018","journal-title":"Am J Hum Genet"},{"key":"B32-20230819","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor.","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"B33-20230819","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13059-017-1353-5","article-title":"Evaluation of in silico algorithms for use with ACMG\/AMP clinical variant interpretation guidelines.","volume":"18","author":"Ghosh","year":"2017","journal-title":"Genome Biol"},{"key":"B34-20230819","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2011.12.022","article-title":"Characteristics of renal cystic and solid lesions based on contrast-enhanced computed tomography of potential kidney donors.","volume":"59","author":"Rule","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"B35-20230819","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1681\/ASN.2016121312","article-title":"Polycystic kidney disease with hyperinsulinemic hypoglycemia caused by a promoter mutation in phosphomannomutase 2.","volume":"28","author":"Cabezas","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"D1","key":"B36-20230819","doi-asserted-by":"crossref","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","article-title":"UniProt: The universal protein knowledgebase.","volume":"45","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B37-20230819","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2215\/CJN.03100608","article-title":"Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.","volume":"4","author":"Nishiura","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B38-20230819","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1053\/j.ajkd.2016.05.016","article-title":"Update on nephrolithiasis: Core curriculum 2016.","volume":"68","author":"Pfau","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B39-20230819","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eururo.2012.03.052","article-title":"Prevalence of kidney stones in the United States.","volume":"62","author":"Scales","year":"2012","journal-title":"Eur Urol"},{"key":"B40-20230819","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2215\/CJN.05181008","article-title":"Asymptomatic nephrolithiasis detected by ultrasound.","volume":"4","author":"Bansal","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2019030298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:31:08Z","timestamp":1786131068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2019030298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,8]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2019030298","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,8]]}}}